Efficacy of PMEG [9-(2-phosphonylmethoxyethyl)guanine] and its prodrug cPr-PMEDAP [9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine in organotypic cultures of normal and papillomavirus ((HPV)-positive keratinocytes

被引：0
|
作者：
Andrei, G
Van den Oord, J
Wolfgang, G
Lee, WA
De Clercq, E
Snoeck, R
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[2] Katholieke Univ Leuven, Lab Morphol & Mol Pathol, Louvain, Belgium
[3] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
ANTIVIRAL RESEARCH | 2004年 / 62卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
84
引用
收藏
页码：A61 / A61
页数：1
相关论文
共 16 条
  • [1] 9-( 2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine (cpr-PMEDAP) as a prodrug of 9-(2-phosphonylmethoxyethyl)guanine (PMEG)
    Compton, ML
    Toole, JJ
    Paborsky, LR
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (04) : 709 - 714
  • [2] SINGLE-DOSE ADMINISTRATION OF 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) AND 9-(2-PHOSPHONYLMETHOXYETHYL)-2,6-DIAMINOPURINE (PMEDAP) IN THE PROPHYLAXIS OF RETROVIRUS INFECTION INVIVO
    NAESENS, L
    BALZARINI, J
    DECLERCQ, E
    ANTIVIRAL RESEARCH, 1991, 16 (01) : 53 - 64
  • [3] EFFICACY OF ORAL 9-(2-PHOSPHONYLMETHOXYETHYL)-2,6-DIAMINOPURINE (PMEDAP) IN THE TREATMENT OF RETROVIRUS AND CYTOMEGALOVIRUS INFECTIONS IN MICE
    NAESENS, L
    NEYTS, J
    BALZARINI, J
    HOLY, A
    ROSENBERG, I
    DECLERCQ, E
    JOURNAL OF MEDICAL VIROLOGY, 1993, 39 (02) : 167 - 172
  • [4] 9-(2-phosphonylmethoxyethyl)-N6-cyclopropyl-2,6-diaminopurine:: A novel prodrug of 9-(2-phosphonyl-methoxyethyl)guanine with improved antitumor efficacy and selectivity in choriocarcinoma-bearing rats
    Naesens, L
    Hatse, S
    Segers, C
    Verbeken, E
    De Clercq, E
    Waer, M
    Balzarini, J
    ONCOLOGY RESEARCH, 1999, 11 (04) : 195 - 203
  • [5] Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase δ and ε in vitro
    Kramata, P
    Downey, KM
    Paborsky, LR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (34) : 21966 - 21971
  • [6] Capillary electrophoresis separation of the new anti-AIDS agents 9-(2-phosphonylmethoxyethyl)adenine and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine in mixtures with some monoribonucleotides or the most common deoxynucleotides
    Vargas, G
    Revilla, A
    Havel, J
    Holy, A
    ELECTROPHORESIS, 1998, 19 (16-17) : 2926 - 2929
  • [7] N6-cyclopropyl-PMEDAP:: A novel derivative of 9-(2-phosphonylmethoxyethyl)2-6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties
    Hatse, S
    Naesens, L
    De Clercq, E
    Balzarini, J
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (02) : 311 - 323
  • [8] Inhibiting effects of PMEG [9-(2-phosphonylmethoxyethyl)guanine] on the growth of human cervical carcinoma xenografts in athymic nude mice
    Andrei, G
    Wolfgang, G
    Lee, B
    Lebeau, I
    De Clercq, E
    Snoeck, R
    ANTIVIRAL RESEARCH, 2005, 65 (03) : A46 - A46
  • [9] Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl) guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI mice
    Balzarini, J
    Vahlenkamp, T
    Egberink, H
    Hartmann, K
    Witvrouw, M
    Pannecouque, C
    Casara, P
    Nave, JF
    DeClercq, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 611 - 616
  • [10] Synthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrier
    de Vrueh, RLA
    Rump, ET
    Sliedregt, LAJM
    Biessen, EAL
    van Berkel, TJC
    Bijsterbosch, MK
    PHARMACEUTICAL RESEARCH, 1999, 16 (08) : 1179 - 1185
12